IP Library Granted Patent US 11,317,968
Granted Patent B2
US 11,317,968 · App. 16/195,121 · Granted May 3, 2022

Methods and compositions for tissue adhesives

Inventors: Kaushal Rege (Chandler, AZ); Huang-Chiao Huang (Phoenix, AZ)
Assignee: Arizona Board of Regents on behalf of Arizona State University
A61B18/203A61B18/18A61B18/20A61K38/18A61K38/1808A61K38/1825A61K38/1841A61K38/19A61K38/39A61K41/0052A61L24/0005A61L24/0015A61L24/0089A61L24/108A61N5/062A61B18/14A61B2018/0063A61B2018/00404A61B2018/00452A61B2018/00494A61B2018/00505A61B2018/1807A61L2300/404A61L2300/414A61L2400/12A61N5/067
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,317,968
App. No.
16/195,121
Granted
May 3, 2022
Kind
B2
Abstract

Disclosed herein are methods of connecting disrupted tissue, tissue repair, treating colorectal disorder and tissue welding. The methods comprise using a bioadhesive composition comprising ELP and light absorbing chromophores and irradiating the bioadhesive tissue.

Claims (27)

1. A bioadhesive composition comprising:

a photothermally responsive composition comprising a network of elastin-like polypeptide (ELP) and a light absorbing chromophore,

wherein the light absorbing chromophore comprises one or more metallic nanoparticles physically entrapped within the network of ELP.

2. The bioadhesive composition of claim 1 , wherein the one or more metallic nanoparticles comprise silver nanoparticles, gold nanorods, or gold nanoparticles, or mixtures thereof.

3. The bioadhesive composition of claim 1 , further comprising an active agent, cells, or a combination thereof physically entrapped within the network of ELP.

4. The bioadhesive composition of claim 3 , wherein the active agent comprises an antibacterial agent.

5. The bioadhesive composition of claim 3 , wherein the active agent comprises an MMP inhibitor, a soluble factor, a cytokine, or a growth factor.

6. The bioadhesive composition of claim 5 , wherein the soluble factor comprises FGF (fibroblast growth factor), TGF-beta, EGF, or a combination thereof.

7. A bioadhesive composition comprising:

a photothermally responsive composition comprising a network of elastin-like polypeptide (ELP) and a light absorbing chromophore,

wherein the light absorbing chromophore comprises one or more metallic nanoparticles physically entrapped within the network of ELP, and

wherein the light absorbing chromophore is configured to convert light to heat upon the application of a directed light beam to the photothermally responsive composition, to a surrounding tissue, or to both, thereby crosslinking the network of ELP in response to the heat.

8. The bioadhesive composition of claim 7 , wherein one or more metallic nanoparticles comprise silver nanoparticles, gold nanorods, or gold nanoparticles, or mixtures thereof.

9. The bioadhesive composition of claim 7 , wherein the directed light beam is a laser.

10. The bioadhesive composition of claim 7 , wherein the light is near infrared.

11. The bioadhesive composition of claim 7 , wherein the directed light beam generates a bulk temperature of at least a portion of the photothermally responsive bioadhesive composition above 60° C.

12. The bioadhesive composition of claim 7 , wherein the directed light beam generates a bulk temperature of at least a portion of the photothermally responsive bioadhesive composition above 80° C.

13. The bioadhesive composition of claim 7 , further comprising an active agent, cells, or a combination thereof physically entrapped within the fibrous network of ELP,

wherein the photothermally responsive composition is configured to release the active agent from the fibrous network of ELP upon the application of the directed light beam.

14. A suture comprising:

at least two fibers, wherein each fiber comprises the bioadhesive composition of claim 1 .

15. The suture of claim 14 , wherein the one or more metallic nanoparticles comprise silver nanoparticles, gold nanorods, or gold nanoparticles, or mixtures thereof.

16. The suture of claim 14 , wherein the directed light beam is a laser.

17. The suture of claim 14 , wherein the light is near infrared.

18. The suture of claim 14 , wherein the directed light beam generates a bulk temperature of at least a portion of the photothermally responsive bioadhesive composition above 60° C.

19. The suture of claim 14 , wherein the directed light beam generates a bulk temperature of at least a portion of the photothermally responsive bioadhesive composition above 80° C.

20. The suture of claim 14 , wherein the light absorbing chromophore in the at least two fibers has a weight percentage between 0.5% and 8%.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 15, 2019
From: ARIZONA STATE UNIVERSITY, TEMPE
To: DEFENSE THREAT REDUCTION AGENCY, US DOD
Reel/Frame 050062/0420 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2018
From: REGE, KAUSHAL; HUANG, HUANG-CHIAO
To: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 047544/0656 →
Continuity (3)
Continuation 14413822
Provisional Application 61682129 · Aug 10, 2012
Related Publication 20190133685A1 · May 9, 2019